IX International Conference on NPS
The conference aims to share knowledge and strengthen collaboration on NPS among multidisciplinary professionals at the international level.
NPS
European Commission adopts measures to control two harmful new drugs amidst health concerns and surge in supply
Today, the European Commission has adopted measures to control two harmful new psychoactive substances (NPS) across the EU. The substances in question — 3-methylmethcathinone (3-MMC) and 3-chloromethcathinone (3-CMC) — are both synthetic...
Abuse Potential of Cathinones in Humans: A Systematic Review
Abstract Introduction and objective: Assessing the abuse potential of new substances with central nervous system activity is essential for preventing possible risks of misuse and addiction. The same methodology is recommended for the...
EMCDDA initial report on the new psychoactive substance 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC)
1-(3-Chlorophenyl)-2-(methylamino) propan-1-one (3-chloromethcathinone, 3-CMC) is a synthetic cathinone stimulant. It is a ring-substituted cathinone, which is structurally related to methcathinone and 4-chloromethcathinone (4-CMC). The...
A series of videos on HIV prevention among people who use stimulant drugs
The UNODC Regional Programme Office for Eastern Europe (Kiev, Ukraine) and Charitable Fund "Humanitarian Action" (Russia) are launching a series of 8 animated videos on the provision of HIV prevention services for people who use stimulants...
Call for Papers: New Drug and other Behavioural Trends During Social-Distancing for the COVID-19 Pandemic
This Special Issue explores new drug and behavioural trends during the Covid-19 Pandemic. We welcome multidisciplinary contributions aimed at enhancing the understanding of how “physical distancing” and other radical changes in our...
Opportunity to Publish a Scientific Article on New Psychoactive Substances!
UNODC is proud to be the co-editor of Special Issue “New Drug and other Behavioural Trends During Social-Distancing for the COVID-19 Pandemic” of the Journal “Emerging Trends in Drugs, Addictions, and Health” and cordially invites you to...
HIV/HCV prevalence and risk behavior among NPS users are a growing public health burden
On April 27, 2021, UNODC Regional Office for Central Asia held a training seminar for specialists of the republican and regional levels responsible for drug dependence treatment and HIV prevention services in the Republic of Uzbekistan. The...
UNODC and partners discuss situation with New Psychoactive Substances in Kyrgyzstan
New psychoactive substances (NPS) are spreading at an unprecedented rate and are becoming a serious health threat and a real problem in drug policy in Central Asian countries. Little is known about the negative impact of NPS on human health...
EMCDDA Technical Report on New Psychoactive Substance
The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid...
